Cutaneous Oncology News

Incorporating mismatch repair screening into daily practice for the management of sebaceous carcinomas may help identify patients with Muir-Torre/Lynch syndrome, which causes genetic predisposition to certain cancers, according to a study.

Solid organ transplantation, age and a history of cancer were significant host risk factors for multiple and subsequent cutaneous squamous cell carcinoma, according to a large chart review.

NEW ORLEANS — Having proven a low recurrence rate, two treatments of the 595 nm pulsed dye laser may be a viable therapy for nonmelanoma skin cancer on the hands of older adult patients, according to a poster presented here.

NEW ORLEANS — A machine learning algorithm was able to differentiate between basal cell and squamous cell carcinomas by identifying biomarkers, according to a poster presented here.

NEW ORLEANS — Integrating genomic testing along with clinical and pathology information will lead to increased accuracy and detection of melanoma in pediatric patients, according to a speaker here.

NEW ORLEANS — BRAF and MEK inhibitors may showed promise as a treatment option for children and adults with histiocytic disorders, according to a presenter here.

NEW ORLEANS — Clinicians should be mindful of unique skin cancer presentations and risks in women with skin of color, according to a speaker here.

NEW ORLEANS — Among Asian American and Pacific Islander subgroups, Southeast Asians had higher rates of metastatic and acral lentiginous melanoma and higher rates of ulceration, according to a presentation here.

While most Mohs surgeons agree on diagnostic differentiations between actinic keratosis and squamous cell carcinoma in situ, variability exists in the interpretation of in situ carcinoma on histological frozen sections, according to a study.

Cutaneous immune-related adverse events are highly dependent on melanoma subtype among immune checkpoint inhibitor therapy recipients, according to a study.